USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Market Overview ScreenersIndustriesCompanies Community Investment Grader

US Market Open: Feb 9, 16:00 PM 2012

NYSE 8079.64 3.34 Index Moved Down

NASDAQ 2927.14 11.28 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ACUR and NKTR...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Acura Pharmaceuticals Inc. and

Nektar Therapeutics

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Acura Pharmaceuticals Inc. and Nektar Therapeutics in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.06

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	87.5%
Values	Daily Returns

Suggest

Acura Pharmaceuticals Inc.

Profile

3.24

Intraday

One Month

^0.01

0.31%

ACUR

NCM

Acura Pharmaceuticals Inc.

P/E	16.91	Day Low	3.20
Open	3.26	P/B Ratio	3.85
Market Cap	146.8M	Volume	54566
Sector	Healthcare	Last Close	3.23
Short Ratio	27.30	Last Traded	2/9/2012
Year High	6.80	Percent Change	0.31%
EBITDA	9.6M	Year Low	2.28
Absolute Change	0.01	Time	Not Applicable
Book Value	0.838	EPS	0.191
Day High	3.31	Industry	Drug Delivery
Target Price	8.00	Current EPS	0.191
Current PE	16.91	This Year PE	Not Applicable

Nektar Therapeutics

Profile

7.01

Intraday

One Month

^(0.20)

2.77%

NKTR

NASDAQ

Nektar Therapeutics

Day Low	6.97	Open	7.19
P/B Ratio	3.57	Market Cap	802.1M
Volume	702048	Sector	Healthcare
Last Close	7.21	Founded	Yes
Short Ratio	14.90	Last Traded	2/9/2012
Year High	11.25	Percent Change	2.77%
EBITDA	-82.0M	Year Low	4.07
Absolute Change	0.20	Time	Not Applicable
Book Value	2.017	EPS	-1.103
Employees	408	Day High	7.35
Target Price	10.67	Current EPS	-1.103
This Year EPS	-1.33	Next Year EPS	-1.38